During the past decade, The First People's Hospital of Yunnan Province conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 4 clinical trials were completed, i.e. on average, 13.8% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 4 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The First People's Hospital of Yunnan Province" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 2 trials sponsored, "Hangzhou Endonom Medtech Co., Ltd." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Beijing Anzhen Hospital" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The First People's Hospital of Yunnan Province" #1 collaborator was "Henan Provincial People's Hospital" with 3 trials as a collaborator, "The First People's Hospital of Yunnan" with 3 trials as a collaborator, "First Affiliated Hospital of Chongqing Medical University" with 2 trials as a collaborator, "Affiliated Hospital of Yunnan University" with 1 trials as a collaborator and "Anhui Provincial Children's Hospital" with 1 trials as a collaborator. Other collaborators include 69 different institutions and companies that were collaborators in the rest 79 trials.

According to Clinical.Site data, the most researched conditions in "The First People's Hospital of Yunnan Province" are "Coronary Artery Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Type 2 Diabetes Mellitus" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Anti Phospholipid Syndrome" (1 trials). Many other conditions were trialed in "The First People's Hospital of Yunnan Province" in a lesser frequency.

Most popular intervention types in "The First People's Hospital of Yunnan Province" are "Drug" (19 trials), "Device" (4 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Mirikizumab" (3 trials), "Acarbose" (1 trials), "Almonertinib" (1 trials) and "Artery Stent Graft System" (1 trials). Other intervention names were less common.

The vast majority of trials in "The First People's Hospital of Yunnan Province" are 32 trials for "All" genders.

Currently, there are NaN active trials in "The First People's Hospital of Yunnan Province". undefined are not yet recruiting, 10 are recruiting, 3 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 8 completed trials in The First People's Hospital of Yunnan Province, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The First People's Hospital of Yunnan Province, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 6 trials that are defined as “Not Applicable".